Investors

Press releases

2024/07/18

Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September

2024/06/28

Number of shares and votes in Medivir AB on 28 June 2024

2024/06/27

Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI

Quarterly report presentations

2024/08/22

Interim Report, January - June 2024 (webcast)

2024/09/13

ESMO Congress

2024/10/15

Maxim Group’s Healthcare Summit

Medivir Corporate Governance documention.

Documentation from Medivir's Annual General Meetings.